Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Perry Karsen Insider Profile
4 Followers
Perry Karsen, Chief Eecutive Officer of Celgene Cellular Therape at Celgene, holds 0.00 shares in Jounce Therapeutics (Ticker: JNCE), holds 164.03K shares in LENZ Therapeutics (Ticker: LENZ), holds 5.00K shares in Intellia Therapeutics (Ticker: NTLA).
Perry Karsen Celgene (CELG)Chief Eecutive Officer of Celgene Cellular Therape
Celgene (CELG)
Chief Eecutive Officer of Celgene Cellular Therape
Not Ranked
Perry Karsen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Perry Karsen holds in companies
Most Profitable Insider Trade
Stock:
OncoMed Pharma
(OMED)
(OMED)
Rating:Informative Buy
Date:Jun 07, 2017 - Jun 07, 2018
Return:-9.60%
The most profitable trade made by Perry Karsen
Perry Karsen's Trading History
Celgene
Dec 18, 2015
―
Uninformative Buy
436.12K
$7.37M
OncoMed Pharma
Apr 23, 2019
―
Uninformative Sell
―
$0.00
Voyager Therapeutics
―
Director
―
―
Intellia Therapeutics
Dec 18, 2020
Director
Uninformative Sell
4.75M
$103.80K
Jounce Therapeutics
May 04, 2023
―
Uninformative Sell
―
$0.00
LENZ Therapeutics
Jul 01, 2021
Director
Uninformative Buy
―
$2.58M
Navidea
Jul 21, 2015
Director
Uninformative Sell
220.00
$1.43K
Agios Pharma
―
Director
―
$0.00
Adynxx
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Perry Karsen's performance on stock
You May Also Like
Perry Karsen insider profile FAQ
What is the percentage of profitable transactions made by Perry Karsen?
The percentage of profitable transactions made by Perry Karsen is ―.
What is the average return per transaction made by Perry Karsen?
The average return per transaction made by Perry Karsen is ―.
What stocks does Perry Karsen hold?
Perry Karsen holds: CELG, OMED, VYGR, NTLA, JNCE, LENZ, NAVB, AGIO, ADYX stocks.
What was Perry Karsen’s latest transaction?
Perry Karsen latest transaction was an Uninformative Sell of ―.
What was Perry Karsen's most profitable transaction?
Perry Karsen’s most profitable transaction was an Informative Buy of OMED stock on June 7, 2017. The return on the trade was -9.60%.
What is Perry Karsen's role in Celgene?
Perry Karsen's role in Celgene is Chief Eecutive Officer of Celgene Cellular Therape.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.